Literature DB >> 20884717

CD30+ lymphoproliferative disorders.

Laurence de Leval, Philippe Gaulard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20884717      PMCID： PMC2948085          DOI： 10.3324/haematol.2010.029256

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

1.  Regulation of CD30 antigen expression and its potential significance for human disease.

Authors:  M E Kadin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome.

Authors:  Karen E Willard-Gallo; Bassam M Badran; Marie Ravoet; Anne Zerghe; Arsène Burny; Philippe Martiat; Michel Goldman; Florence Roufosse; Catherine Sibille
Journal:  Exp Hematol       Date:  2005-10       Impact factor: 3.084

4.  JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis.

Authors:  George Z Rassidakis; Athanasios Thomaides; Coralyn Atwell; Richard Ford; Dan Jones; Francois-Xavier Claret; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

Review 5.  CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

Authors:  B Falini; S Pileri; G Pizzolo; H Dürkop; L Flenghi; F Stirpe; M F Martelli; H Stein
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

6.  The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.

Authors:  Faye Yuan-Yi Hsu; Patrick B Johnston; Kathleen A Burke; Yi Zhao
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

7.  Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations.

Authors:  Eva Geissinger; Petra Sadler; Sabine Roth; Tina Grieb; Bernhard Puppe; Nora Müller; Peter Reimer; Claudia S Vetter-Kauczok; Jörg Wenzel; Irina Bonzheim; Thomas Rüdiger; Hans Konrad Müller-Hermelink; Andreas Rosenwald
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

8.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

9.  Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease.

Authors:  H Dürkop; U Latza; M Hummel; F Eitelbach; B Seed; H Stein
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

10.  Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.

Authors:  Irina Bonzheim; Eva Geissinger; Sabine Roth; Andreas Zettl; Alexander Marx; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2004-08-05       Impact factor: 22.113
View more
  11 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Authors:  Bettina Bisig; Aurélien de Reyniès; Christophe Bonnet; Pierre Sujobert; David S Rickman; Teresa Marafioti; Georges Delsol; Laurence Lamant; Philippe Gaulard; Laurence de Leval
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 3.  Role of CD30 targeting in malignant lymphoma.

Authors:  Anita Kumar; Anas Younes
Journal:  Curr Treat Options Oncol       Date:  2014-06

4.  CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Authors:  Shimin Hu; Zijun Y Xu-Monette; Aarthi Balasubramanyam; Ganiraju C Manyam; Carlo Visco; Alexander Tzankov; Wei-min Liu; Roberto N Miranda; Li Zhang; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Qin Huang; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Jane N Winter; Mingzhi Zhang; Ling Li; Michael B Møller; Miguel A Piris; Yong Li; Ronald S Go; Lin Wu; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-01-23       Impact factor: 22.113

5.  Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells.

Authors:  Sudhakiranmayi Kuravi; Janice Cheng; Gabrielle Fangman; Kishore Polireddy; Sophia McCormick; Tara L Lin; Anurag K Singh; Sunil Abhyankar; Siddhartha Ganguly; Danny R Welch; Roy A Jensen; Joseph P McGuirk; Ramesh Balusu
Journal:  Mol Cancer Res       Date:  2021-01-29       Impact factor: 6.333

6.  The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.

Authors:  Xiaoxiao Hao; Xiaolei Wei; Fen Huang; Yongqiang Wei; Hong Zeng; Linwei Xu; Qinjun Zhou; Ru Feng
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  Cluster of differentiation 30 expression in lacrimal gland and conjunctival tissues in patients with Sjögren's syndrome: Case series.

Authors:  Akiko Ogawa; Yoko Ogawa; Shin Mukai; Eisuke Shimizu; Masataka Kuwana; Yutaka Kawakami; Kazuo Tsubota
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 8.  The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).

Authors:  Ivonne A Montes-Mojarro; Julia Steinhilber; Irina Bonzheim; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2018-04-04       Impact factor: 6.639

9.  CD30 Is Dispensable for T-Cell Responses to Influenza Virus and Lymphocytic Choriomeningitis Virus Clone 13 but Contributes to Age-Associated T-Cell Expansion in Mice.

Authors:  Angela C Zhou; Laura M Snell; Michael E Wortzman; Tania H Watts
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

10.  The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1.

Authors:  Jingxi Zhang; Zuoqiao Wu; Anton Savin; Mihye Yang; Ying-Han R Hsu; Eugeniu Jantuan; Julinor T C Bacani; Robert J Ingham
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.